EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Navigating the complexities of drug development for metallo-β-lactamase inhibitors

Nakita Reddy iD, Alessandra Moraes Balieiro iD, José Rogério A Silva iD, Christiaan A Gouws, Awelani Mutshembele iD, Per I Arvidsson iD, Hendrik G Kruger iD, Thavendran Govender, Tricia Naicker iD

RSC Medicinal Chemistry · 2025 · 16 (8) · 3393-3415

DOI: 10.1039/d5md00035a ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift RSC Medicinal Chemistry, 2025. Verfasst von Nakita Reddy und 8 weiteren Autor:innen. Beteiligte Einrichtung: Catalysis and Peptide Research Unit, University of KwaZulu-Natal Durban 4000 South Africa naickert1@ukzn.ac.za. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 176 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, South African Medical Research Council.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Standardized approaches to MBL inhibitor development are vital. This work highlights the benefits of uniform methodologies while addressing key preclinical challenges to bridge the gap toward successful clinical translation.

Autor:innen und Institutionen

  • Catalysis and Peptide Research Unit, University of KwaZulu-Natal Durban 4000 South Africa naickert1@ukzn.ac.za.
  • Office of AIDS and TB, South African Medical Research Council Pretoria 0084 South Africa.
  • Laboratory of Computer Modeling of Molecular Biosystems, Federal University of Pará Belém 66075-110 Pará Brazil.
  • Science for Life Laboratory, Drug Discovery & Development Platform & Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet Stockholm 17177 Swed…
  • Department of Chemistry, University of Zululand Private Bag X1001 KwaDlangezwa 3886 South Africa govenderthav@icloud.com.

ORCID-Profile: Nakita Reddy, Alessandra Moraes Balieiro, José Rogério A Silva, Awelani Mutshembele, Per I Arvidsson, Hendrik G Kruger, Tricia Naicker

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • South African Medical Research Council
  • National Research Foundation

Zitieren

APA

Reddy, N., Balieiro, A. M., Silva, J. R. A., Gouws, C. A., Mutshembele, A., Arvidsson, P. I., Kruger, H. G., Govender, T., & Naicker, T. (2025). Navigating the complexities of drug development for metallo-β-lactamase inhibitors. RSC Medicinal Chemistry, 16(8), 3393-3415. https://doi.org/10.1039/d5md00035a

Vancouver

Reddy N, Balieiro AM, Silva JRA, Gouws CA, Mutshembele A, Arvidsson PI, et al. Navigating the complexities of drug development for metallo-β-lactamase inhibitors. RSC Medicinal Chemistry. 2025;16(8):3393-3415. doi:10.1039/d5md00035a

BibTeX
@article{Reddy2025,
  author = {Reddy, Nakita and Balieiro, Alessandra Moraes and Silva, José Rogério A and Gouws, Christiaan A and Mutshembele, Awelani and Arvidsson, Per I and Kruger, Hendrik G and Govender, Thavendran and Naicker, Tricia},
  title = {Navigating the complexities of drug development for metallo-β-lactamase inhibitors},
  journal = {RSC Medicinal Chemistry},
  year = {2025},
  volume = {16},
  number = {8},
  pages = {3393--3415},
  doi = {10.1039/d5md00035a}
}
Kostenlos starten →